Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

GILD – Gilead Sciences, Inc.

Gilead Sciences, Inc.
GILD
$112.39
Name : Gilead Sciences, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $140,108,742,656.00
EPSttm : 0.38
finviz dynamic chart for GILD
Gilead Sciences, Inc.
$112.39
0.45%
$0.5

Float Short %

1.8

Margin Of Safety %

-1

Put/Call OI Ratio

0.98

EPS Next Q Diff

0.03

EPS Last/This Y

7.57

EPS This/Next Y

0.4

Price

112.39

Target Price

113.64

Analyst Recom

1.87

Performance Q

21.67

Relative Volume

1.15

Beta

0.27

Ticker: GILD




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-05GILD115.410.810.36225971
2025-03-06GILD116.060.800.62230136
2025-03-07GILD117.580.820.52231991
2025-03-10GILD117.220.830.66231085
2025-03-11GILD114.410.851.19236932
2025-03-12GILD113.990.851.29239871
2025-03-13GILD113.330.860.07245051
2025-03-14GILD111.430.940.87235772
2025-03-17GILD112.250.910.47237980
2025-03-18GILD109.920.901.54239125
2025-03-19GILD107.510.920.95243521
2025-03-20GILD105.860.912.48247172
2025-03-21GILD107.160.890.88248682
2025-03-24GILD106.650.910.96214639
2025-03-25GILD107.950.921.76217991
2025-03-26GILD109.180.952.45223332
2025-03-27GILD111.141.020.50232679
2025-03-28GILD111.81.020.52238122
2025-03-31GILD1120.970.59228282
2025-04-01GILD111.280.951.03235150
2025-04-02GILD111.930.971.10237184
2025-04-03GILD112.20.980.37240541
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-05GILD115.44232.511377.57.94
2025-03-06GILD116.04232.511366.97.94
2025-03-07GILD117.41232.511444.57.94
2025-03-10GILD117.19232.511283.97.94
2025-03-11GILD114.41232.511027.17.94
2025-03-12GILD113.94232.511257.77.95
2025-03-13GILD113.33232.511240.07.95
2025-03-14GILD111.44232.511110.57.95
2025-03-17GILD112.26232.511394.17.95
2025-03-18GILD110.22232.511095.77.95
2025-03-19GILD107.51232.511021.67.95
2025-03-20GILD105.87232.511132.17.95
2025-03-21GILD106.94232.511427.67.95
2025-03-24GILD106.74232.511273.07.95
2025-03-25GILD107.89232.511435.57.95
2025-03-26GILD109.27232.511459.27.95
2025-03-27GILD111.14232.611509.77.95
2025-03-28GILD111.79232.611376.27.95
2025-03-31GILD111.98232.611329.97.95
2025-04-01GILD111.28232.611229.57.95
2025-04-02GILD111.89232.611374.17.95
2025-04-03GILD112.39232.611367.37.95
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-05GILD-25.181.011.70
2025-03-06GILD-25.181.011.70
2025-03-07GILD-25.181.011.70
2025-03-10GILD-25.181.341.70
2025-03-11GILD-25.181.341.70
2025-03-12GILD-25.181.341.82
2025-03-13GILD-25.601.341.82
2025-03-14GILD-24.401.341.82
2025-03-17GILD-24.401.341.82
2025-03-18GILD-23.521.341.82
2025-03-19GILD-23.521.341.82
2025-03-20GILD-23.521.341.82
2025-03-21GILD-23.521.341.82
2025-03-24GILD-23.521.341.82
2025-03-25GILD-23.521.341.82
2025-03-26GILD-23.521.341.80
2025-03-27GILD-23.521.341.80
2025-03-28GILD-23.521.341.80
2025-03-31GILD-23.521.341.80
2025-04-01GILD-23.521.341.80
2025-04-02GILD-23.521.341.80
2025-04-03GILD-23.471.341.80
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.9

Avg. EPS Est. Current Quarter

1.75

Avg. EPS Est. Next Quarter

1.93

Insider Transactions

-23.47

Institutional Transactions

1.34

Beta

0.27

Average Sales Estimate Current Quarter

6772

Average Sales Estimate Next Quarter

6946

Fair Value

111.45

Quality Score

61

Growth Score

76

Sentiment Score

88

Actual DrawDown %

6.3

Max Drawdown 5-Year %

-30.5

Target Price

113.64

P/E

306.16

Forward P/E

13.28

PEG

12.25

P/S

4.87

P/B

7.24

P/Free Cash Flow

13.58

EPS

0.37

Average EPS Est. Cur. Y​

7.95

EPS Next Y. (Est.)

8.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.67

Relative Volume

1.15

Return on Equity vs Sector %

-17.3

Return on Equity vs Industry %

-24.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

11367.3
Gilead Sciences, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 17600
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.
stock quote shares GILD – Gilead Sciences, Inc. Stock Price stock today
news today GILD – Gilead Sciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GILD – Gilead Sciences, Inc. yahoo finance google finance
stock history GILD – Gilead Sciences, Inc. invest stock market
stock prices GILD premarket after hours
ticker GILD fair value insiders trading